ArticleActa pharmacologica Sinica2022

FX5, a non-steroidal glucocorticoid receptor antagonist, ameliorates diabetic cognitive impairment in mice.

Dan-Yang Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.